<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Reprod Dev</journal-id><journal-id journal-id-type="iso-abbrev">J. Reprod. Dev</journal-id><journal-id journal-id-type="publisher-id">JRD</journal-id><journal-title-group><journal-title>The Journal of Reproduction and Development</journal-title></journal-title-group><issn pub-type="ppub">0916-8818</issn><issn pub-type="epub">1348-4400</issn><publisher><publisher-name>The Society for Reproduction and Development</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23719562</article-id><article-id pub-id-type="pmc">3944355</article-id><article-id pub-id-type="publisher-id">2012-169</article-id><article-id pub-id-type="doi">10.1262/jrd.2012-169</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Insulin-like Growth Factor 1 mRNA Expression in the Uterus of
Streptozotocin-treated Diabetic Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>MANABE</surname><given-names>Yoshie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>TOCHIGI</surname><given-names>Makoto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>MORIWAKI</surname><given-names>Akiyoshi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>TAKEUCHI</surname><given-names>Sakae</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>TAKAHASHI</surname><given-names>Sumio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1)</label>The Graduate School of Natural Science and Technology,
Okayama University, Okayama 700-8530, Japan</aff><aff id="aff2"><label>2)</label>Chugoku Gakuen University, Okayama 701-0197, Japan</aff></contrib-group><author-notes><corresp>Correspondence: S Takahashi (e-mail: <email xlink:href="stakaha@cc.okayama-u.ac.jp">stakaha@cc.okayama-u.ac.jp</email>)</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>5</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2013</year></pub-date><volume>59</volume><issue>4</issue><fpage>398</fpage><lpage>404</lpage><history><date date-type="received"><day>15</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9;2013 Society for Reproduction and Development</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><title>Abstract</title><p> Reproductive functions decline with the onset of diabetes in female mice. Diabetic mice
have smaller uteri with an underdeveloped endometrium, suggesting diminished
estrogen-induced growth. We aimed to clarify the changes in the estrous cycle and in
insulin-like growth factor 1 (IGF1) expression in the uteri of streptozotocin
(STZ)-treated diabetic mice, because IGF1 is one of the main growth factors involved in
estrogen-induced uterine growth. ICR female mice were intraperitoneally administered STZ
(10 mg/100 g BW), and blood glucose levels were determined. Mice with blood glucose levels
&#x0003e; 200 mg/dl were classified as diabetic mice. The onset of diabetes was associated with
acyclic estrous cycles. Diabetes was also induced with STZ in ovariectomized mice. Uterine
<italic>Igf1</italic> mRNA levels were reduced in ovariectomized STZ-treated diabetic
mice. Estrogen is known to stimulate <italic>Igf1</italic> mRNA expression in the uterus,
but estrogen action was abolished in the uteri of STZ-treated diabetic mice. mRNA
expressions of estrogen receptor &#x003b1; (ER&#x003b1;) and steroid hormone receptor coactivators
(SRC-1/<italic>Ncoa1</italic>, SRC-2/<italic>Ncoa2</italic>,
SRC-3/<italic>Ncoa3</italic> and CBP/p300/<italic>Crebbp</italic>) were reduced in the
uteri of ovariectomized STZ-treated diabetic mice. The present study demonstrates that
diabetes induces a decline in female reproductive functions in mice. <italic>Igf1</italic>
expression in ovariectomized diabetic female mice was decreased, and decreased
responsiveness to estrogen in the uteri of diabetic mice is probably associated with a
reduction in ER&#x003b1; and steroid receptor coactivator mRNA expression.</p></abstract><kwd-group><kwd>Diabetes</kwd><kwd>Insulin-like growth factor 1 (IGF1)</kwd><kwd>Mouse</kwd><kwd>Uterus</kwd></kwd-group></article-meta></front><body><p>Diabetes mellitus is a complex, heterogeneous disorder with common symptoms being
hyperglycemia and a relative or absolute lack of insulin. Diabetes mellitus is always fatal if
not treated, and even when treated, serious complications such as blindness, kidney disease,
and circulatory or circulatory-based problems may develop. We previously found severe
disorders in pituitary and reproductive functions in streptozotocin (STZ)-induced diabetic
mice, and indicated that diabetes mellitus induces disorders in the pituitary-peripheral
target systems [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref>]. We focused on changes in uterine functions in diabetic mice. STZ was used for
pharmacological induction of diabetes.</p><p>Diabetic female mice show irregular or acyclic estrous cycles, suggesting a decline in
reproductive function [<xref rid="r3" ref-type="bibr">3</xref>]. Diminished pituitary function
in diabetic rats and mice has also been reported [<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]. Furthermore, diabetes induces changes in
uterine structures and functions in rats [<xref rid="r3" ref-type="bibr">3</xref>], and uteri
of diabetic mice are smaller in size and atrophic, suggesting a diminished response to ovarian
steroid hormones [<xref rid="r5" ref-type="bibr">5</xref>]. Interestingly, Garris demonstrated
an increase in lipoapoptotic endometrial epithelial cells in diabetic (<italic>db/db</italic>)
mice [<xref rid="r6" ref-type="bibr">6</xref>].</p><p>Proliferation of endometrial luminal and glandular epithelial cells is regulated by estrogen,
and proliferation of endometrial stromal cells is regulated by estrogen and progestin [<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r8" ref-type="bibr">8</xref>]. Estrogen and
progestin stimulate the production of growth factors in endometrial cells, which in turn
stimulate DNA synthesis in endometrial cells [<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]. Insulin-like
growth factor 1 (IGF1) is one of the growth factors that govern the proliferation of
endometrial cells. IGF1 stimulates DNA synthesis in endometrial luminal epithelial cells and
stromal cells through IGF1 receptors (IGF1R) [<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]. IGF1 expression in the uterus is stimulated by
estrogen [<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>]. IGF-binding protein-3 (IGFBP3) modulates the actions of IGF1 by binding to the
IGF1 molecule, resulting in obstruction of IGF1 action or prolongation of the half-life of
IGF1 [<xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r24" ref-type="bibr">24</xref>].
In endometrial stromal cell cultures, IGFBP3 was shown to inhibit IGF1-induced DNA synthesis
[<xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r26" ref-type="bibr">26</xref>]. In
this study, we analyzed three genes of the IGF system, <italic>Igf1</italic>,
<italic>Igfbp3</italic> and <italic>Igf1r</italic>, to clarify diabetes-related changes in
the uterus.</p><p>The action of estrogen on <italic>Igf1</italic> mRNA expression is mediated through estrogen
receptors (ERs) [<xref rid="r27" ref-type="bibr">27</xref>]. Estrogen receptors need several
coactivators or corepressors to exert their transcriptional actions [<xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r29" ref-type="bibr">29</xref>]. The steroid receptor
coactivator (SRC) family includes SRC-1/NCoA1, SRC-2/NCoA2/TIF2/GRIP1 and
SRC-3/NCoA3/AIB1/ACTR/RAC3/TRAM-1/pCIP, and is required for transcription of steroid receptors
[<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>,<xref rid="r32" ref-type="bibr">32</xref>,<xref rid="r33" ref-type="bibr">33</xref>]. cAMP
response element-binding protein (CREB)-binding protein (CBP)/p300 also regulates
transcriptional activities of steroid receptors [<xref rid="r31" ref-type="bibr">31</xref>,
<xref rid="r34" ref-type="bibr">34</xref>, <xref rid="r35" ref-type="bibr">35</xref>]. We
also studied the effects of diabetes on SRC and CBP/p300 mRNA expression.</p><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Animals</title><p>Adult female mice of the ICR strain were used. Mice were housed in a
temperature-controlled animal room and were fed a commercial diet (CA-1; CLEA Japan,
Osaka, Japan) and tap water. Vaginal smears were monitored daily to observe estrous
cycles. Animal care and experiments were conducted in accordance with the Guidelines for
Animal Experimentation of Okayama University, Japan.</p></sec><sec><title>STZ treatment</title><p>Mice were intraperitoneally administered STZ (Sigma-Aldrich, St. Louis, MO, USA) at a
dose of 10 mg/100 g body weight three times every two weeks from 3 months of age. STZ was
dissolved in 0.05 M citric acid (65 mg/ml). Control mice were given vehicle only. In the
other experiment, ovariectomized mice were administered STZ (10 mg/100g body weight) once.
All mice were deprived of food for 16 h before STZ treatment.</p></sec><sec><title>Blood glucose measurement</title><p>Blood samples were obtained from the tail vein under light ether anesthesia. Blood
glucose level was determined by the glucose oxidase method. Blood glucose levels were
measured every week during experiments. Mice with blood glucose levels above 200 mg/dl
were classified as diabetic.</p></sec><sec><title>Histological analysis</title><p>Eleven weeks after STZ treatment, uteri were collected from diabetic mice at diestrus,
and uteri were collected from control mice at estrus or diestrus at the age of 5 months.
Uteri were fixed with Bouin's solution. The uteri were embedded in Paraplast, and coronal
uterine serial sections (5 &#x000b5;m thickness) were cut. The sections were stained with
hematoxylin and eosin.</p></sec><sec><title>Ovariectomy and estradiol-17&#x003b2; (E2) treatment</title><p>Female mice were ovariectomized at 2 months of age under light ether anesthesia. One week
after ovariectomy, mice were treated with STZ as described above. Two weeks after the STZ
treatment, E2 (0.25 or 2.5 &#x000b5;g) or sesame oil was given subcutaneously. Uteri were
collected 48 h after E2 treatment.</p></sec><sec><title>cDNA synthesis and real-time PCR</title><p>Total RNA was prepared from uteri using a single-step method [<xref rid="r36" ref-type="bibr">36</xref>]. Total RNA was reverse-transcribed using ThermoScript Reverse
Transcriptase (Invitrogen, Carlsbad, CA, USA) with random 6-mer primers according to the
manufacturer's instructions. Each PCR was performed using primer sets specific for
<italic>Igf1</italic>, <italic>Igfbp3</italic>, <italic>Igf1r</italic>, <italic>ERa,
Ncoa1</italic>, <italic>Ncoa2</italic>, <italic>Ncoa3</italic>, <italic>Crebbp</italic>
or <italic>Rpl19</italic> cDNAs (<xref rid="tbl_001" ref-type="table">Table
1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title> Sequences of primers used in real-time PCR</title></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Name</td><td align="center" valign="middle" rowspan="1" colspan="1">Sequence</td><td align="center" valign="middle" rowspan="1" colspan="1">Length (bp)</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>ERa</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">GGCTGGAGATTCTGATGATTGG</td><td align="center" valign="middle" rowspan="2" colspan="1">55</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">TTCCCCGGGTGTTCCAT</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Igf1</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">AAAGCAGCCCCGCTCTATCC</td><td align="center" valign="middle" rowspan="2" colspan="1">57</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">CTTCTGAGTCTTGGGCATGTCA</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Igfbp3</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">AAGCACCTACCTCCCCTCCCAA</td><td align="center" valign="middle" rowspan="2" colspan="1">98</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">TGCTGGGGACAACCTGGCTTTC</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Igf1r</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">GCTTCTGTGAACCCCGAGTATTT</td><td align="center" valign="middle" rowspan="2" colspan="1">82</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">TGGTGATCTTCTCTCGAGCTACCT</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Ncoa1</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">GCTCCAGCAAACTCCACCTACTT</td><td align="center" valign="middle" rowspan="2" colspan="1">44</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">AATGTTTGCGTTTCCACCTG</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Ncoa2</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">CCCCGTGGCCTGAGAGCAT</td><td align="center" valign="middle" rowspan="2" colspan="1">44</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">GAAGTTCCGCAAGGCCAGATACAG</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Ncoa3</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">GCTTGGGCCACCTTCTAACG</td><td align="center" valign="middle" rowspan="2" colspan="1">43</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">CTTGAGCTGGGTATGTCTGTCC</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Crebbp</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">GTCTTTGCCTTTTCGTCAGC</td><td align="center" valign="middle" rowspan="2" colspan="1">49</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">CCACATACTGCCAGGGTTCT</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1"><italic>Rpl19</italic></td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Forward</td><td align="left" valign="middle" rowspan="1" colspan="1">CCCGTCAGCAGATCAGGAA</td><td align="center" valign="middle" rowspan="2" colspan="1">58</td></tr><tr><td align="left" valign="middle" style="padding-left:15pt" rowspan="1" colspan="1">Reverse</td><td align="left" valign="middle" rowspan="1" colspan="1">GTCACAGGCTTGCGGATGA</td></tr></tbody></table></table-wrap>). Real-time PCR analysis was conducted using an Applied Biosystems 7300
Real-Time PCR System (Foster City, CA, USA) and SYBR Premix Ex Taq (Takara Bio, Otsu,
Japan). Amplifications were done in 15-&#x000b5;l aliquots according to the manufacturer's
instructions. DNA polymerase was activated by heating at 95 C for 10 sec, followed by 40
cycles of amplification including denaturation at 95 C for 5 sec, and annealing at 60 C
for 31 sec. mRNA levels were normalized to ribosomal protein L19 (<italic>Rpl19</italic>)
mRNA levels [<xref rid="r37" ref-type="bibr">37</xref>].</p></sec><sec><title>Statistical analysis</title><p>The differences in means among groups were analyzed by analysis of variance followed by
Tukey's test.</p></sec></sec><sec sec-type="results" id="s2"><title>Results</title><sec><title>Blood glucose levels, estrous cycle and uterine histology</title><p>Blood glucose levels in STZ-treated mice started to increase 4 to 5 weeks after the first
STZ injection, while in vehicle-treated control mice, they did not change (<xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p> Effect of STZ-treated diabetes on the estrous cycle and blood glucose levels: a
summary of the estrous cycle and blood glucose levels (the number above each line,
mg/dl) of diabetic mice and control mice. Intact female mice were intraperitoneally
administered STZ at a dose of 10 mg/100 g body weight or the vehicle three times
every two weeks at 3 months of age (arrows). Vaginal smears were checked daily (P,
proestrus; E, estrus; D, diestrus), and blood glucose levels were measured every
week.</p></caption><graphic xlink:href="jrd-59-398-g001"/></fig>). Vehicle-treated control mice continued to show estrous cycle, but most of the
diabetic mice entered a continuous diestrous state, suggesting cessation of ovulation.
Eleven weeks after the STZ treatment, the blood glucose levels remained significantly
higher in the diabetic mice (386 &#x000b1; 23 mg/dl, n=5) than in the control mice (107 &#x000b1; 5 mg/dl,
n=5, P&#x0003c;0.0001), and then the uteri of the diabetic mice and control mice were collected
for histological analysis and mRNA measurements.</p><p>Histological analysis showed that endometrial epithelia and stroma were less developed in
the diabetic mice than in the control mice (<xref ref-type="fig" rid="fig_002">Fig. 2A and
B</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p> Effect of STZ-treated diabetes on uterine morphology. Uteri were obtained from
adult female mice at 5 months of age (eleven weeks after the STZ treatment). (A, C)
Control mice at diestrus; (B, D) diabetic mice at diestrus. G, uterine gland; M,
myometrium. Bar = 250 &#x000b5;m (A, B); bar = 50 &#x000b5;m (C, D).</p></caption><graphic xlink:href="jrd-59-398-g002"/></fig>). The myometrium in the diabetic mice was also less developed. The endometrial
luminal epithelial cell layer was significantly thinner in the diabetic mice than in the
control mice (<xref ref-type="fig" rid="fig_002">Fig. 2C and D</xref>).</p></sec><sec><title>Uterine Igf1, Igfbp3 and Igf1r mRNA expression in STZ-treated diabetic mice</title><p><italic>Igf1</italic> mRNA levels in control mice were higher during diestrus than during
estrus (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p> Effect of STZ-treated diabetes on uterine <italic>Igf1</italic>,
<italic>Igfbp3</italic> and <italic>Igf1r</italic> mRNA expressions. Uteri were
obtained from adult female mice at 5 months of age. <italic>Igf1</italic>,
<italic>Igfbp3</italic> and <italic>Igf1r</italic> mRNA expressions in the uterus
of vehicle-treated control mice (E, estrus; D, diestrus) and STZ-treated diabetic
mice (diestrus) were analyzed by real-time PCR. Each column represents the mean &#x000b1;
SEM for 5 animals per group. *P&#x0003c;0.05 compared with control mice at estrus.</p></caption><graphic xlink:href="jrd-59-398-g003"/></fig>). <italic>Igf1</italic> mRNA levels in diabetic mice during diestrus appeared to be
higher than in control mice at estrus, but the difference was not statistically
significant because of the large variation in mRNA levels in the diabetic mice. There were
no differences in <italic>Igfbp3</italic> or <italic>Igf1r</italic> mRNA levels between
control and diabetic mice.</p></sec><sec><title>Uterine ERa, Ncoa1, Ncoa2, Ncoa3 and Crebbp mRNA expression in the STZ-treated
diabetic mice</title><p><italic>ERa</italic> mRNA levels in control mice were higher during diestrus than during
estrus (<xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p> Effect of STZ-treated diabetes on uterine <italic>ERa</italic>,
<italic>Ncoa1</italic>, <italic>Ncoa2</italic>, <italic>Ncoa3</italic> and
<italic>Crebbp</italic> mRNA expressions. Uteri were obtained from adult female
mice at 5 months of age. <italic>ERa</italic>, <italic>Ncoa1</italic>,
<italic>Ncoa2</italic>, <italic>Ncoa3</italic> and <italic>Crebbp</italic> mRNA
expressions in the uterus of vehicle-treated control mice (E, estrus; D, diestrus)
and STZ-treated diabetic mice (diestrus) were analyzed by real-time PCR. Each column
represents the mean &#x000b1; SEM for 5 animals per group. *P&#x0003c;0.05; **P&#x0003c;0.01 compared
with control mice at estrus. <sup>###</sup>P&#x0003c;0.001 compared with control mice at
diestrus.</p></caption><graphic xlink:href="jrd-59-398-g004"/></fig>). <italic>ERa</italic> mRNA levels in diabetic mice during diestrus were higher
than in control mice at diestrus. <italic>Ncoa1</italic> mRNA levels in control mice were
higher during diestrus than during estrus. <italic>Ncoa1, Ncoa2, Ncoa3</italic> and
<italic>Crebb</italic> mRNA levels during diestrus in diabetic mice were not different
from those in control mice at diestrus.</p></sec><sec><title>E2 effects on uterine Igf1, Igfbp3 and Igf1r mRNA expression in ovariectomized
STZ-treated diabetic mice</title><p>The effect of diabetes on estrogen responsiveness was studied in terms of
<italic>Igf1</italic>, <italic>Igfbp3</italic> and <italic>Igf1r</italic> mRNA
expression. In control mice, E2 increased <italic>Igf1</italic> mRNA levels, and decreased
<italic>Igfbp3</italic> and <italic>Igf1r</italic> mRNA levels, which is in agreement
with our previous studies [<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r38" ref-type="bibr">38</xref>]. In the
diabetic mice, E2 treatment did not affect <italic>Igf1</italic>, <italic>Igf1r</italic>
and <italic>Igfbp3</italic> mRNA levels, and their levels were lower than in the control
mice given the corresponding treatment (<xref ref-type="fig" rid="fig_005">Fig.
5</xref><fig orientation="portrait" fig-type="figure" id="fig_005" position="float"><label>Fig. 5.</label><caption><p> Effect of E2 on uterine <italic>Igf1</italic>, <italic>Igfbp3</italic> and
<italic>Igf1r</italic> mRNA expression in ovariectomized STZ-induced diabetic
mice. Ovariectomized STZ-induced diabetic mice were given a single injection of E2
(0.25 or 2.5 &#x000b5;g) or sesame oil as the vehicle. Uteri were collected 48 h after
treatment, <italic>Igf1</italic>, <italic>Igfbp3</italic> and <italic>Igf1r</italic>
mRNA levels were analyzed by real-time PCR. Each column represents the mean &#x000b1; SEM
for 5 animals per group. The mRNA levels are shown as relative values compared with
those of control mice given sesame oil. *P&#x0003c;0.05; **P&#x0003c;0.01; ***P&#x0003c;0.001,
****P&#x0003c;0.0001 compared with control mice given sesame oil. <sup>#</sup>P&#x0003c;0.05;
<sup>##</sup>P&#x0003c;0.01; <sup>###</sup>P&#x0003c;0.001 compared with the control mice
given the corresponding treatment.</p></caption><graphic xlink:href="jrd-59-398-g005"/></fig>).</p></sec><sec><title>E2 effects on uterine ERa, Ncoa1, Ncoa2, Ncoa3 and Crebbp mRNA expression in the
ovariectomized STZ-treated diabetic mice</title><p><italic>ERa</italic> mRNA levels were lower in the diabetic mice than in the control
mice. E2 treatment did not affect uterine <italic>ERa</italic> mRNA expression in either
the diabetic mice or the control mice (<xref ref-type="fig" rid="fig_006">Fig.
6</xref><fig orientation="portrait" fig-type="figure" id="fig_006" position="float"><label>Fig. 6.</label><caption><p> Effect of E2 on uterine <italic>ERa</italic>, <italic>Ncoa1</italic>,
<italic>Ncoa2</italic>, <italic>Ncoa3</italic> and <italic>Crebbp</italic> mRNA
expression in ovariectomized STZ-induced diabetic mice. Ovariectomized and
STZ-induced diabetic mice were given a single injection of E2 (0.25 or 2.5 &#x000b5;g) or
sesame oil as the vehicle. <italic>ERa</italic>, <italic>Ncoa1</italic>,
<italic>Ncoa2</italic>, <italic>Ncoa3</italic> and <italic>Crebbp</italic> mRNA
levels were analyzed by real-time PCR. Each column represents the mean &#x000b1; SEM for 5
animals per group. The mRNA levels are shown as relative values compared with those
of control mice given sesame oil. *P&#x0003c;0.05 compared with control mice.
<sup>#</sup>P&#x0003c;0.05; <sup>##</sup>P&#x0003c;0.01; <sup>###</sup>P&#x0003c;0.001;
<sup>####</sup>P&#x0003c;0.0001 compared with the control mice given the corresponding
treatment.</p></caption><graphic xlink:href="jrd-59-398-g006"/></fig>). <italic>Ncoa1, Ncoa2, Ncoa3 and Crebbp mRNA</italic> levels were lower in the
diabetic mice than in the control mice. E2 treatment decreased <italic>Ncoa1</italic>,
<italic>Ncoa2</italic> and <italic>Crebbp</italic> mRNA levels in the control mice, but
did not in the diabetic mice.</p></sec></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>Diabetes mellitus affects female reproductive functions in humans. Post-menarcheal women
with type 1 diabetes commonly have irregular menstrual cycles, and polycystic ovaries are
frequently observed [<xref rid="r39" ref-type="bibr">39</xref>, <xref rid="r40" ref-type="bibr">40</xref>]. Severely altered reproductive functions have been reported in
diabetic mutant (<italic>db</italic>) and STZ-treated diabetic female mice [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r41" ref-type="bibr">41</xref>]. The present
study clearly demonstrated that mice with high blood glucose levels induced by STZ treatment
showed no estrous cycle, indicating cessation of ovulation. Diabetic conditions may affect
the hypothalamo-pituitary system that regulates gonadotropin secretion [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r40" ref-type="bibr">40</xref>]. The uteri
of the STZ-treated diabetic mice were less developed, suggesting reduced estrogen secretion
or diminished responsiveness to estrogen. Thus, there is strong evidence, both from the
present study and previous studies, that female reproductive function is severely affected
by diabetes.</p><p>The uterus of the diabetic mouse was smaller than that of the control mouse. The
endometrial epithelial and stromal cell layers were thinner in the diabetic mouse. The
myometrial cell layer was also thinner in the diabetic mouse. Therefore, the regulatory
mechanism of uterine growth may be affected under STZ-induced diabetic conditions. The
growth of endometrial epithelial and stromal cells is regulated by growth factors.
<italic>Igf1</italic> mRNA was localized in endometrial and myometrial tissues in rat and
mouse uteri [<xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r21" ref-type="bibr">21</xref>]. <italic>Igf1</italic> mRNA levels
in the uterus changed during the estrous cycle, and its levels at diestrus were higher than
those at estrus, which is consistent with a previous report [<xref rid="r42" ref-type="bibr">42</xref>]. IGF1 is one of the growth factors involved in endometrial growth, and
possibly works in a paracrine and autocrine manner [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r15" ref-type="bibr">15</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r18" ref-type="bibr">18</xref>]. <italic>Igf1</italic> mRNA did not
differ between control and diabetic mice, indicating that constitutive production of IGF1
may not be affected by diabetes, which was consistent with a previous study done in
STZ-treated rats [<xref rid="r43" ref-type="bibr">43</xref>]. A similar finding was reported
in STZ-treated diabetic mice, although the <italic>Igf1</italic> mRNA levels were determined
under human chorionic gonadotropin stimulation [<xref rid="r44" ref-type="bibr">44</xref>].
<italic>Igfbp3</italic> mRNA levels did not differ between diabetic mice and control mice,
either. The present finding and previous reports may suggest that IGF1 was not a primary
factor responsible for the atrophy of uteri in diabetic mice.</p><p>Some of the growth factors and related proteins expressed in endometrial epithelial and
stromal cells are regulated by estrogen and progestin. In the uterus, transcription of
<italic>Igf1</italic>, <italic>Igfbp3</italic> and <italic>Igf1r</italic> is regulated by
estrogen [<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r20" ref-type="bibr">20</xref>, <xref rid="r25" ref-type="bibr">25</xref>, <xref rid="r38" ref-type="bibr">38</xref>]. In the present study, E2 stimulated uterine <italic>Igf1</italic> mRNA
expression, and inhibited <italic>Igfbp3</italic> and <italic>Igf1r</italic> mRNA expression
in control mice but did not affect uterine <italic>Igf1</italic>, <italic>Igfbp3</italic>
and <italic>Igf1r</italic> mRNA expression in the diabetic mice. Thus, the responsiveness to
estrogen in terms of IGF1 systems was diminished in diabetic conditions, which was
consistent with a previous report in rats [<xref rid="r43" ref-type="bibr">43</xref>]. It is
highly probable that the reduction or lack of response to estrogen in the uterus of diabetic
mice is closely associated with atrophy of the uterus.</p><p>An increase in <italic>ERa</italic> mRNA levels in diabetic mice was evident, and this was
possibly due to low estrogen levels in diabetic mice, if the regulatory mechanism of ER gene
expression was not affected in the diabetic mice. Estrogen production was decreased in
diabetic rats [<xref rid="r45" ref-type="bibr">45</xref>], and blood estrogen levels may be
decreased in diabetic mice. Uterine ER mRNA expression was upregulated when physiological
concentrations of E2 were administered [<xref rid="r46" ref-type="bibr">46</xref>] and was
downregulated by higher concentrations [<xref rid="r47" ref-type="bibr">47</xref>, <xref rid="r48" ref-type="bibr">48</xref>]. In the present study, <italic>ERa</italic> mRNA
levels appeared to be decreased by E2 treatment in ovariectomized control mice.</p><p>A possible reason for the changes in estrogen responsiveness in the uterus of
ovariectomized diabetic mice is the change in estrogen receptor expression. In the uteri of
ovariectomized STZ-treated diabetic mice, <italic>ERa</italic> mRNA levels were
significantly decreased, which suggests that ER levels were decreased in the uterus,
although ER&#x003b1; levels were not determined in the present study. It is probable that the loss
of estrogen-induced changes in <italic>Igf1</italic>, <italic>Igfbp3</italic> and
<italic>Igf1r</italic> mRNA expression in the uterus is partly due to a decrease in ER
expression.</p><p>Nuclear receptors are transcription factors, and their actions are aided by coactivators
including SRCs and CBP/p300. Several nuclear receptor coactivators are expressed in the
uterus [<xref rid="r49" ref-type="bibr">49</xref>]. In ovariectomized STZ-treated diabetic
mice, mRNA expression of SRCs and CBP/p300 were decreased in the uterus, which may be
associated with the loss of responsiveness to estrogen in diabetic mice.</p><p>SRC-1 exerts a major role in regulating ER and progesterone receptor (PR) in the uterus
[<xref rid="r31" ref-type="bibr">31</xref>]. SRC-1 knockout mice
(<italic>SRC-1<sup>&#x02013;/&#x02013;</sup></italic>) are fertile, but their uteri showed less response
in the decidualization [<xref rid="r50" ref-type="bibr">50</xref>]. SRC-2 is coexpressed
with SRC-1 in the uterus during pregnancy, and SRC-2 knockout affects the induction of the
decidual reaction under the stimulation of estrogen and progestin [<xref rid="r51" ref-type="bibr">51</xref>], and is required for pregnancy [<xref rid="r52" ref-type="bibr">52</xref>]. SRC-2 is also involved in the modulation of estrogen, Wnt, and bone
morphogenetic (BMP) growth factor signaling pathways in the uterus [<xref rid="r51" ref-type="bibr">51</xref>]. SRC-3 expression is low in the mouse uterus [<xref rid="r53" ref-type="bibr">53</xref>, <xref rid="r54" ref-type="bibr">54</xref>], but in the present study,
SRC-3 mRNA was detected. The reason for this discrepancy is not clear. SRC-3 knockout female
mice showed disrupted reproductive functions, delayed puberty and prolonged estrous cycle
[<xref rid="r51" ref-type="bibr">51</xref>]. In SRC-3 knockout mice, liver
<italic>Igf1</italic> mRNA levels were reduced [<xref rid="r55" ref-type="bibr">55</xref>], suggesting the involvement of SRC-3 in <italic>Igf1</italic> mRNA expression.
In the present study, SRC-1, SRC-2 and SRC-3 mRNA levels were decreased in the uteri of
STZ-treated diabetic mice, probably leading to the reduced growth of the uterus, although
molecular mechanisms of the interactions of SRCs with ER or PR are not clear.</p><p>CBP/p300 acts as essential coactivators for many transcription factors [<xref rid="r35" ref-type="bibr">35</xref>, <xref rid="r56" ref-type="bibr">56</xref>]. p300
potentiates ERs through the A/B regions of both ER&#x003b1; and ER&#x003b2; [<xref rid="r57" ref-type="bibr">57</xref>]. The decrease in <italic>Crebbp</italic> mRNA expression may lead to the
diminished transcriptional activation of ER-dependent genes in endometrial cells.</p><p>SRCs mRNA and CBP/p300 mRNA levels were downregulated by E2 treatment over the course of 48
h, which suggests that these expressions may be associated with E2 and ER levels. On the
contrary, previous reports showed that E2 did not induce significant changes in SRC mRNA
expression in the uterus of ovariectomized rats over the course of 24 h [<xref rid="r49" ref-type="bibr">49</xref>]. The discrepancy may be partly due to the difference
in the duration of E2 treatment. The decrease in SRC mRNA expression may be not induced by
diabetic conditions directly. In diabetic mice, the E2-induced changes in SRC mRNA and
CBP/p300 mRNA were not detected. The loss of E2 responsiveness of uterine cells in terms of
SRCs and CBP/p300 expression in diabetic mice may be also responsible for the diminished
growth of uteri.</p><p>The present study clearly demonstrates diabetes-induced declines in female reproductive
functions: no ovulation and atrophy of uteri. Several changes in gene expression, such as in
the IGF system-related genes, estrogen receptors, and coactivators, were demonstrated in
ovariectomized diabetic mice.</p></sec></body><back><ack><title>Acknowledgment</title><p>This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan
Society for the Promotion of Science to ST.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Osawa</surname><given-names>T</given-names></name></person-group>
<article-title>Decreased proliferation of pituitary cells of
streptozotocin-induced diabetic rats in response to estradiol-17-beta</article-title>.
<source>Acta Anatomica</source><year>1994</year>; <volume>151</volume>:
<fpage>239</fpage>&#x02013;<lpage>244</lpage>
<pub-id pub-id-type="pmid">7740918</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Oomizu</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group>
<article-title>Proliferation of pituitary cells in streptozotocin-induced
diabetic mice: effect of insulin and estrogen</article-title>. <source>Zool
Sci</source><year>1994</year>; <volume>11</volume>:
<fpage>445</fpage>&#x02013;<lpage>449</lpage></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Johnson</surname><given-names>LM</given-names></name><name><surname>Sidman</surname><given-names>RL</given-names></name></person-group>
<article-title>A reproductive endocrine profile in the diabetes (db)
mutant mouse</article-title>. <source>Biol Reprod</source><year>1979</year>;
<volume>20</volume>: <fpage>552</fpage>&#x02013;<lpage>559</lpage>
<pub-id pub-id-type="pmid">378276</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Manabe</surname><given-names>Y</given-names></name><name><surname>Nakatomi</surname><given-names>K</given-names></name><name><surname>Chikaraishi</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Immunocytochemical and immunoelectron-microscopic study of
somatotrophs in ICR and nonobese diabetic mice</article-title>. <source>Cells Tissues
Organs</source><year>2000</year>; <volume>166</volume>:
<fpage>31</fpage>&#x02013;<lpage>39</lpage>
<pub-id pub-id-type="pmid">10671753</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Kirkland</surname><given-names>JL</given-names></name><name><surname>Barrett</surname><given-names>GN</given-names></name><name><surname>Stancel</surname><given-names>GM</given-names></name></person-group>
<article-title>Decreased cell division of the uterine luminal epithelium
of diabetic rats in response to 17 beta-estradiol</article-title>. <source>Endocrinology
</source><year>1981</year>; <volume>109</volume>: <fpage>316</fpage>&#x02013;<lpage>318</lpage>
<pub-id pub-id-type="pmid">7016511</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Garris</surname><given-names>DR</given-names></name></person-group>
<article-title>Diabetes (db/db) mutation-induced endometrial epithelial
lipoapoptosis: ultrastructural and cytochemical analysis of reproductive tract
atrophy</article-title>. <source>Reprod Biol Endocrinol </source><year>2005</year>;
<volume>3</volume>: <fpage>15</fpage>
<pub-id pub-id-type="pmid">15857516</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Huet</surname></name><name><surname>Hudson</surname><given-names>YM</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group>
<article-title>Cell type-specific localization of c-<italic>myc</italic>
protein in the mouse uterus: modulation by steroid hormones and analysis of the
periimplantation period</article-title>. <source>Endocrinology
</source><year>1989</year>; <volume>125</volume>:
<fpage>1683</fpage>&#x02013;<lpage>1690</lpage>
<pub-id pub-id-type="pmid">2667965</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Huet</surname></name><name><surname>Hudson</surname><given-names>YM</given-names></name><name><surname>Chakraborty</surname><given-names>C</given-names></name><name><surname>De</surname><given-names>SK</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group>
<article-title>Estrogen regulates the synthesis of epidermal growth
factor in mouse uterine epithelial cells</article-title>. <source>Mol Endocrinol
</source><year>1990</year>; <volume>4</volume>: <fpage>510</fpage>&#x02013;<lpage>523</lpage>
<pub-id pub-id-type="pmid">2342484</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Tomooka</surname><given-names>Y</given-names></name><name><surname>DiAugustine</surname><given-names>RP</given-names></name><name><surname>McLachlan</surname><given-names>JA</given-names></name></person-group>
<article-title>Proliferation of mouse uterine epithelial cells <italic>in
vitro</italic></article-title>. <source>Endocrinology </source><year>1986</year>;
<volume>118</volume>: <fpage>1011</fpage>&#x02013;<lpage>1018</lpage>
<pub-id pub-id-type="pmid">3004888</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>DiAugustine</surname><given-names>RP</given-names></name><name><surname>Petrusz</surname><given-names>P</given-names></name><name><surname>Bell</surname><given-names>GI</given-names></name><name><surname>Brown</surname><given-names>CF</given-names></name><name><surname>Korach</surname><given-names>KS</given-names></name><name><surname>McLachlan</surname><given-names>JA</given-names></name><name><surname>Teng</surname><given-names>CT</given-names></name></person-group>
<article-title>Influence of estrogens on mouse uterine epidermal growth
factor precursor protein and messenger ribonucleic acid</article-title>.
<source>Endocrinology </source><year>1988</year>; <volume>122</volume>:
<fpage>2355</fpage>&#x02013;<lpage>2363</lpage>
<pub-id pub-id-type="pmid">3286224</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Das</surname><given-names>SK</given-names></name><name><surname>Tsukamura</surname><given-names>H</given-names></name><name><surname>Paria</surname><given-names>BC</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name></person-group>
<article-title>Differential expression of epidermal growth factor
receptor (EGF-R) gene and regulation of EGF-R bioactivity by progesterone and estrogen
in the adult mouse uterus</article-title>. <source>Endocrinology
</source><year>1994</year>; <volume>134</volume>: <fpage>971</fpage>&#x02013;<lpage>981</lpage>
<pub-id pub-id-type="pmid">7507841</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Cooke</surname><given-names>PS</given-names></name><name><surname>Buchanan</surname><given-names>DL</given-names></name><name><surname>Lubahn</surname><given-names>DB</given-names></name><name><surname>Cunha</surname><given-names>GR</given-names></name></person-group>
<article-title>Mechanism of estrogen action: lesson from the estrogen
receptor-&#x003b1; knockout mouse</article-title>. <source>Biol Reprod
</source><year>1998</year>; <volume>59</volume>: <fpage>470</fpage>&#x02013;<lpage>475</lpage>
<pub-id pub-id-type="pmid">9716542</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Cooke</surname><given-names>PS</given-names></name><name><surname>Buchanan</surname><given-names>DL</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Setiawan</surname><given-names>Y</given-names></name><name><surname>Brody</surname><given-names>J</given-names></name><name><surname>Korach</surname><given-names>KS</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Lubahn</surname><given-names>DB</given-names></name><name><surname>Cunha</surname><given-names>GR</given-names></name></person-group>
<article-title>Stromal estrogen receptors mediate mitogenic effects of
estradiol on uterine epithelium</article-title>. <source>Proc Natl Acad Sci
USA</source><year>1997</year>; <volume>94</volume>:
<fpage>6535</fpage>&#x02013;<lpage>6540</lpage>
<pub-id pub-id-type="pmid">9177253</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Beck</surname><given-names>CA</given-names></name><name><surname>Garner</surname><given-names>CW</given-names></name></person-group>
<article-title>Stimulation of DNA synthesis in rat uterine cells by
growth factors and uterine extracts</article-title>. <source>Mol Cell Endocrinol
</source><year>1992</year>; <volume>84</volume>: <fpage>109</fpage>&#x02013;<lpage>118</lpage>
<pub-id pub-id-type="pmid">1639215</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Shiraga</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Fukamachi</surname><given-names>H</given-names></name></person-group>
<article-title>Insulin-like growth factor-I stimulates proliferation of
mouse uterine epithelial cells in primary culture</article-title>. <source>ProcSoc Exp
Biol Med</source><year>1997</year>; <volume>215</volume>:
<fpage>412</fpage>&#x02013;<lpage>417</lpage>
</mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Kapur</surname><given-names>S</given-names></name><name><surname>Tamada</surname><given-names>H</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name><name><surname>Andrews</surname><given-names>GK</given-names></name></person-group>
<article-title>Expression of insulin-like growth factor-I (IGF-I) and its
receptor in the peri-implantation mouse uterus, and cell-specific regulation of IGF-I
gene expression by estradiol and progesterone</article-title>. <source>Biol Reprod
</source><year>1992</year>; <volume>46</volume>: <fpage>208</fpage>&#x02013;<lpage>219</lpage>
<pub-id pub-id-type="pmid">1311209</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Hardy</surname><given-names>MP</given-names></name><name><surname>Kurita</surname><given-names>T</given-names></name><name><surname>Cunha</surname><given-names>GR</given-names></name><name><surname>Cooke</surname><given-names>PS</given-names></name></person-group>
<article-title>Role of systemic and local IGF-I in the effects of
estrogen on growth and epithelial proliferation of mouse uterus</article-title>.
<source>Endocrinology </source><year>2002</year>; <volume>143</volume>:
<fpage>2673</fpage>&#x02013;<lpage>2679</lpage>
<pub-id pub-id-type="pmid">12072401</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Insulin-like growth factor-I stimulated DNA replication in
mouse endometrial stromal cells</article-title>. <source>J Reprod Dev
</source><year>2005</year>; <volume>51</volume>: <fpage>305</fpage>&#x02013;<lpage>313</lpage>
<pub-id pub-id-type="pmid">15724079</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group>
<article-title>Estradiol-17&#x003b2; regulates mouse uterine epithelial cell
proliferation through insulin-like growth factor 1 signaling</article-title>.
<source>Proc Natl Acad Sci USA</source><year>2007</year>; <volume>104</volume>:
<fpage>15847</fpage>&#x02013;<lpage>15851</lpage>
<pub-id pub-id-type="pmid">17895382</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Murphy</surname><given-names>LJ</given-names></name><name><surname>Murphy</surname><given-names>LC</given-names></name><name><surname>Friesen</surname><given-names>HG</given-names></name></person-group>
<article-title>Estrogen induces insulin-like growth factor-I expression
in the rat uterus</article-title>. <source>Mol Endocrinol </source><year>1987</year>;
<volume>1</volume>: <fpage>445</fpage>&#x02013;<lpage>450</lpage>
<pub-id pub-id-type="pmid">2484720</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Ghahary</surname><given-names>A</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>LJ</given-names></name></person-group>
<article-title>Localization of the sites of synthesis and action of
insulin-like growth factor-I in the rat uterus</article-title>. <source>Mol Endocrinol
</source><year>1990</year>; <volume>4</volume>: <fpage>191</fpage>&#x02013;<lpage>195</lpage>
<pub-id pub-id-type="pmid">2158621</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Ohtsuki</surname><given-names>T</given-names></name><name><surname>Otsuki</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Alternative leader-exon usage in mouse IGF-I mRNA
variants: class 1 and class 2 IGF-I mRNAs</article-title>. <source>Zool Sci
</source><year>2007</year>; <volume>24</volume>: <fpage>241</fpage>&#x02013;<lpage>247</lpage>
<pub-id pub-id-type="pmid">17551244</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Hwa</surname><given-names>V</given-names></name><name><surname>Oh</surname><given-names>Y</given-names></name><name><surname>Rosenfeld</surname><given-names>RG</given-names></name></person-group>
<article-title>The insulin-like growth factor-binding protein (IGFBP)
superfamily</article-title>. <source>Endocr Rev </source><year>1999</year>;
<volume>20</volume>: <fpage>761</fpage>&#x02013;<lpage>787</lpage>
<pub-id pub-id-type="pmid">10605625</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Duan</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name></person-group>
<article-title>Roles of insulin-like growth factor (IGF) binding proteins
in regulating IGF actions</article-title>. <source>Gen Comp Endocrinol
</source><year>2005</year>; <volume>142</volume>: <fpage>44</fpage>&#x02013;<lpage>52</lpage>
<pub-id pub-id-type="pmid">15862547</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Maekawa</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Kanayama</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Estradiol, progesterone, and tansforming growth factor &#x003b1;
regulate insulin-like growth factor binding protein-3 (IGFBP3) expression in mouse
endometrial cells</article-title>. <source>Zool Sci </source><year>2009</year>;
<volume>26</volume>: <fpage>131</fpage>&#x02013;<lpage>138</lpage>
<pub-id pub-id-type="pmid">19341330</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Maekawa</surname><given-names>T</given-names></name><name><surname>Sakuma</surname><given-names>A</given-names></name><name><surname>Taniuchi</surname><given-names>S</given-names></name><name><surname>Ogo</surname><given-names>Y</given-names></name><name><surname>Iguchi</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Transforming growth factor &#x003b1; mRNA expression and its
possible roles in mouse endometrial stromal cells</article-title>. <source>Zool Sci
</source><year>2012</year>; <volume>29</volume>: <fpage>377</fpage>&#x02013;<lpage>383</lpage>
<pub-id pub-id-type="pmid">22639808</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Klotz</surname><given-names>DM</given-names></name><name><surname>Hewitt</surname><given-names>SC</given-names></name><name><surname>Ciana</surname><given-names>P</given-names></name><name><surname>Raviscioni</surname><given-names>M</given-names></name><name><surname>Lindzey</surname><given-names>JK</given-names></name><name><surname>Foley</surname><given-names>J</given-names></name><name><surname>Maggi</surname><given-names>A</given-names></name><name><surname>DiAugustine</surname><given-names>RP</given-names></name><name><surname>Korach</surname><given-names>KS</given-names></name></person-group>
<article-title>Requirement of estrogen receptor-&#x003b1; in insulin-like growth
factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen
receptor cross-talk</article-title>. <source>J Biol Chem </source><year>2002</year>;
<volume>277</volume>: <fpage>8531</fpage>&#x02013;<lpage>8537</lpage>
<pub-id pub-id-type="pmid">11751931</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group>
<article-title>The coregulator exchange in transcriptional functions of
nuclear receptors</article-title>. <source>Genes Dev </source><year>2000</year>;
<volume>14</volume>: <fpage>121</fpage>&#x02013;<lpage>141</lpage>
<pub-id pub-id-type="pmid">10652267</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>McKenna</surname><given-names>NJ</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>Combinatorial control of gene expression by nuclear
receptors and coregulators</article-title>. <source>Cell </source><year>2002</year>;
<volume>108</volume>: <fpage>465</fpage>&#x02013;<lpage>474</lpage>
<pub-id pub-id-type="pmid">11909518</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>O&#x000f1;ate</surname><given-names>SA</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>Sequence and characterization of a coactivator for the
steroid hormone receptor superfamily</article-title>. <source>Science
</source><year>1995</year>; <volume>270</volume>:
<fpage>1354</fpage>&#x02013;<lpage>1357</lpage>
<pub-id pub-id-type="pmid">7481822</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Heinzel</surname><given-names>T</given-names></name><name><surname>Torchia</surname><given-names>J</given-names></name><name><surname>Kurokawa</surname><given-names>R</given-names></name><name><surname>Gloss</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Heyman</surname><given-names>RA</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group>
<article-title>A CBP integrator complex mediates transcriptional
activation and AP-1 inhibition by nuclear receptors</article-title>. <source>Cell
</source><year>1996</year>; <volume>85</volume>: <fpage>403</fpage>&#x02013;<lpage>414</lpage>
<pub-id pub-id-type="pmid">8616895</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Anzick</surname><given-names>SL</given-names></name><name><surname>Kononen</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>RL</given-names></name><name><surname>Azorsa</surname><given-names>DO</given-names></name><name><surname>Tanner</surname><given-names>MM</given-names></name><name><surname>Guan</surname><given-names>XY</given-names></name><name><surname>Sauter</surname><given-names>G</given-names></name><name><surname>Kallioniemi</surname><given-names>OP</given-names></name><name><surname>Trent</surname><given-names>JM</given-names></name><name><surname>Meltzer</surname><given-names>PS</given-names></name></person-group>
<article-title>AIB1, a steroid receptor coactivator amplified in breast
and ovarian cancer</article-title>. <source>Science </source><year>1997</year>;
<volume>277</volume>: <fpage>965</fpage>&#x02013;<lpage>968</lpage>
<pub-id pub-id-type="pmid">9252329</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Gomes</surname><given-names>PJ</given-names></name><name><surname>Chen</surname><given-names>JD</given-names></name></person-group>
<article-title>RAC3, a steroid/nuclear receptor-associated coactivator
that is related to SRC-1 and TIF2</article-title>. <source>Proc Natl Acad Sci
USA</source><year>1997</year>; <volume>94</volume>:
<fpage>8479</fpage>&#x02013;<lpage>8484</lpage>
<pub-id pub-id-type="pmid">9238002</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Chakravarti</surname><given-names>D</given-names></name><name><surname>LaMorte</surname><given-names>VJ</given-names></name><name><surname>Nelson</surname><given-names>MC</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Schulman</surname><given-names>IG</given-names></name><name><surname>Juguilon</surname><given-names>H</given-names></name><name><surname>Montminy</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name></person-group>
<article-title>Role of CBP/P300 in nuclear receptor
signalling</article-title>. <source>Nature </source><year>1996</year>;
<volume>383</volume>: <fpage>99</fpage>&#x02013;<lpage>103</lpage>
<pub-id pub-id-type="pmid">8779723</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Torchia</surname><given-names>J</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Inostroza</surname><given-names>J</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name><name><surname>Westin</surname><given-names>S</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group>
<article-title>The transcriptional co-activator p/CIP binds CBP and
mediates nuclear-receptor function</article-title>. <source>Nature
</source><year>1997</year>; <volume>387</volume>: <fpage>677</fpage>&#x02013;<lpage>684</lpage>
<pub-id pub-id-type="pmid">9192892</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Chomczynski</surname><given-names>P</given-names></name><name><surname>Sacchi</surname><given-names>N</given-names></name></person-group>
<article-title>Single-step method of RNA isolation by acid
guanidiniumthiocyanate-phenol-chloroform extraction</article-title>. <source>Anal
Biochem </source><year>1987</year>; <volume>162</volume>:
<fpage>156</fpage>&#x02013;<lpage>159</lpage>
<pub-id pub-id-type="pmid">2440339</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Meyuhas</surname><given-names>O</given-names></name><name><surname>Perry</surname><given-names>RP</given-names></name></person-group>
<article-title>Construction and identification of cDNA clones for mouse
ribosomal proteins: application for the study of r-protein gene
expression</article-title>. <source>Gene </source><year>1980</year>;
<volume>10</volume>: <fpage>113</fpage>&#x02013;<lpage>129</lpage>
<pub-id pub-id-type="pmid">6993285</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Ohtsuki</surname><given-names>T</given-names></name><name><surname>Otsuki</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Maekawa</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Akasaka</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name></person-group>
<article-title>Organ-specific and age-dependent expression of
insulin-like growth factor-I (IGF-I) mRNA variants: IGF-IA and IB mRNAs in the
mouse</article-title>. <source>Zool</source><source>Sci </source><year>2005</year>;
<volume>22</volume>: <fpage>1011</fpage>&#x02013;<lpage>1021</lpage>
</mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Adcock</surname><given-names>CJ</given-names></name><name><surname>Perry</surname><given-names>LA</given-names></name><name><surname>Lindsell</surname><given-names>DR</given-names></name><name><surname>Taylor</surname><given-names>AM</given-names></name><name><surname>Holly</surname><given-names>JM</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name></person-group>
<article-title>Menstrual irregularities are more common in adolescents
with type 1 diabetes: association with poor glycaemic control and weight
gain</article-title>. <source>Diabet Med </source><year>1994</year>;
<volume>11</volume>: <fpage>465</fpage>&#x02013;<lpage>470</lpage>
<pub-id pub-id-type="pmid">8088124</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Arrais</surname><given-names>RF</given-names></name><name><surname>Dib</surname><given-names>SA</given-names></name></person-group>
<article-title>The hypothalamus-pituitary-ovary axis and type 1 diabetes
mellitus: a mini review</article-title>. <source>Hum Reprod </source><year>2006</year>;
<volume>21</volume>: <fpage>327</fpage>&#x02013;<lpage>337</lpage>
<pub-id pub-id-type="pmid">16239312</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group><name><surname>Tesone</surname><given-names>M</given-names></name><name><surname>Ladenheim</surname><given-names>RG</given-names></name><name><surname>Oliveira</surname></name><name><surname>Filho</surname><given-names>RM</given-names></name><name><surname>Chiauzzi</surname><given-names>VA</given-names></name><name><surname>Foglia</surname><given-names>VG</given-names></name><name><surname>Charreau</surname><given-names>EH</given-names></name></person-group>
<article-title>Ovarian dysfunction in streptozotocin-induced diabetic
rats</article-title>. <source>Proc Soc Exp Biol Med </source><year>1983</year>;
<volume>174</volume>: <fpage>123</fpage>&#x02013;<lpage>130</lpage>
<pub-id pub-id-type="pmid">6314340</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group><name><surname>Sahlin</surname><given-names>L</given-names></name><name><surname>Norstedt</surname><given-names>G</given-names></name><name><surname>Eriksson</surname><given-names>H</given-names></name></person-group>
<article-title>Estrogen regulation of the estrogen receptor and
insulinlike growth factor-I in the rat uterus: a potential coupling between effects of
estrogen and IGF-I</article-title>. <source>Steroids </source><year>1994</year>;
<volume>59</volume>: <fpage>421</fpage>&#x02013;<lpage>430</lpage>
<pub-id pub-id-type="pmid">7974526</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group><name><surname>Murphy</surname><given-names>LJ</given-names></name></person-group>
<article-title>Impaired estrogen-induced uterine insulin-like growth
factor-I gene expression in the streptozotocin diabetic rat</article-title>.
<source>Diabetologia </source><year>1988</year>; <volume>31</volume>:
<fpage>842</fpage>&#x02013;<lpage>847</lpage>
<pub-id pub-id-type="pmid">3069530</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group><name><surname>Zakaria</surname><given-names>R</given-names></name><name><surname>Rajikin</surname><given-names>MH</given-names></name><name><surname>Yaacob</surname><given-names>NS</given-names></name><name><surname>Nor</surname><given-names>NM</given-names></name></person-group>
<article-title>Diabetes alters the mRNA expression of insulin-like growth
factors and their receptors in the mouse fallopian tube and uterus during the
preimplantation stages</article-title>. <source>Reprod</source><source>Biol
</source><year>2007</year>; <volume>7</volume>: <fpage>41</fpage>&#x02013;<lpage>53</lpage>
</mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group><name><surname>Chabrolle</surname><given-names>C</given-names></name><name><surname>Jeanpierre</surname><given-names>E</given-names></name><name><surname>Tosca</surname><given-names>L</given-names></name><name><surname>Rame</surname><given-names>C</given-names></name><name><surname>Dupont</surname><given-names>J</given-names></name></person-group>
<article-title>Effects of high levels of glucose on the steroidogenesis
and the expression of adiponectin receptors in rat ovarian cells</article-title>.
<source>Reprod Biol Endocrinol </source><year>2008</year>; <volume>6</volume>:
<fpage>11</fpage>
<pub-id pub-id-type="pmid">18353182</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group><name><surname>Bergman</surname><given-names>MD</given-names></name><name><surname>Schachter</surname><given-names>BS</given-names></name><name><surname>Karelus</surname><given-names>K</given-names></name><name><surname>Combatsiaris</surname><given-names>EP</given-names></name><name><surname>Garcia</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>JF</given-names></name></person-group>
<article-title>Up-regulation of the uterine estrogen receptor and its
messenger ribonucleic acid during the mouse estrous cycle: the role of
estradiol</article-title>. <source>Endocrinology </source><year>1992</year>;
<volume>130</volume>: <fpage>1923</fpage>&#x02013;<lpage>1930</lpage>
<pub-id pub-id-type="pmid">1547720</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group><name><surname>Shupnik</surname><given-names>MA</given-names></name><name><surname>Gordon</surname><given-names>MS</given-names></name><name><surname>Chin</surname><given-names>WW</given-names></name></person-group>
<article-title>Tissue-specific regulation of rat estrogen receptor
mRNAs</article-title>. <source>Mol Endocrinol </source><year>1989</year>;
<volume>3</volume>: <fpage>660</fpage>&#x02013;<lpage>665</lpage>
<pub-id pub-id-type="pmid">2725529</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group><name><surname>Medlock</surname><given-names>KL</given-names></name><name><surname>Lyttle</surname><given-names>CR</given-names></name><name><surname>Kelepouris</surname><given-names>N</given-names></name><name><surname>Newman</surname><given-names>ED</given-names></name><name><surname>Sheehan</surname><given-names>DM</given-names></name></person-group>
<article-title>Estradiol down-regulation of the rat uterine estrogen
receptor</article-title>. <source>Proc Soc Exp Biol Med </source><year>1991</year>;
<volume>196</volume>: <fpage>293</fpage>&#x02013;<lpage>300</lpage>
<pub-id pub-id-type="pmid">1998006</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group><name><surname>Nephew</surname><given-names>KP</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Hlaing</surname><given-names>M</given-names></name><name><surname>Ahluwalia</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>SD</given-names></name><name><surname>Long</surname><given-names>X</given-names></name><name><surname>Hyder</surname><given-names>SM</given-names></name><name><surname>Bigsby</surname><given-names>RM</given-names></name></person-group>
<article-title>Expression of estrogen receptor coactivators in the rat
uterus</article-title>. <source>Biol Reprod </source><year>2000</year>;
<volume>63</volume>: <fpage>361</fpage>&#x02013;<lpage>367</lpage>
<pub-id pub-id-type="pmid">10906038</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>Partial hormone resistance in mice with disruption of the
steroid receptor coactivator-1 (SRC-1) gene</article-title>. <source>Science
</source><year>1998</year>; <volume>279</volume>:
<fpage>1922</fpage>&#x02013;<lpage>1925</lpage>
<pub-id pub-id-type="pmid">9506940</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Han</surname><given-names>SJ</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name><name><surname>Lydon</surname><given-names>JP</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name><name><surname>Demayo</surname><given-names>FJ</given-names></name></person-group>
<article-title>The p160 steroid receptor coactivator 2, SRC-2, regulates
murine endometrial function and regulates progesterone-independent and -dependent gene
expression</article-title>. <source>Endocrinology </source><year>2007</year>;
<volume>148</volume>: <fpage>4238</fpage>&#x02013;<lpage>4250</lpage>
<pub-id pub-id-type="pmid">17556502</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group><name><surname>Gehin</surname><given-names>M</given-names></name><name><surname>Mark</surname><given-names>M</given-names></name><name><surname>Dennefeld</surname><given-names>C</given-names></name><name><surname>Dierich</surname><given-names>A</given-names></name><name><surname>Gronemeyer</surname><given-names>H</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group>
<article-title>The function of TIF2/GRIP1 in mouse reproduction is
distinct from those of SRC-1 and p/CIP</article-title>. <source>Mol Cell Biol
</source><year>2002</year>; <volume>22</volume>:
<fpage>5923</fpage>&#x02013;<lpage>5937</lpage>
<pub-id pub-id-type="pmid">12138202</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><name><surname>Yoshida</surname></name><name><surname>Komiya</surname><given-names>H</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>The steroid receptor coactivator SRC-3
(p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female
reproductive function, and mammary gland development</article-title>. <source>Proc Natl
Acad Sci USA</source><year>2000</year>; <volume>97</volume>:
<fpage>6379</fpage>&#x02013;<lpage>6384</lpage>
<pub-id pub-id-type="pmid">10823921</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group><name><surname>Han</surname><given-names>SJ</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>Steroid receptor coactivator (SRC)-1 and SRC-3
differentially modulate tissue-specific activation functions of the progesterone
receptor</article-title>. <source>Mol Endocrinol </source><year>2006</year>;
<volume>20</volume>: <fpage>45</fpage>&#x02013;<lpage>55</lpage>
<pub-id pub-id-type="pmid">16141356</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Hermanson</surname><given-names>O</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Herman</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Szeto</surname><given-names>D</given-names></name><name><surname>Gleiberman</surname><given-names>A</given-names></name><name><surname>Krones</surname><given-names>A</given-names></name><name><surname>Pratt</surname><given-names>K</given-names></name><name><surname>Rosenfeld</surname><given-names>R</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group>
<article-title>Regulation of somatic growth by the p160 coactivator
p/CIP</article-title>. <source>Proc Natl Acad Sci USA</source><year>2000</year>;
<volume>97</volume>: <fpage>13549</fpage>&#x02013;<lpage>13554</lpage>
<pub-id pub-id-type="pmid">11087842</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group><name><surname>McKenna</surname><given-names>NJ</given-names></name><name><surname>Lanz</surname><given-names>RB</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name></person-group>
<article-title>Nuclear receptor coregulators: cellular and molecular
biology</article-title>. <source>Endocr Rev </source><year>1999</year>;
<volume>20</volume>: <fpage>321</fpage>&#x02013;<lpage>344</lpage>
<pub-id pub-id-type="pmid">10368774</pub-id></mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Kitamoto</surname><given-names>T</given-names></name><name><surname>Masuhiro</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Kase</surname><given-names>T</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name><name><surname>Yanagisawa</surname><given-names>J</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name></person-group>
<article-title>p300 mediates functional synergism between AF-1 and AF-2
of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B
domains</article-title>. <source>J Biol Chem</source><year>2000</year>;
<volume>275</volume>: <fpage>15645</fpage>&#x02013;<lpage>15651</lpage>
<pub-id pub-id-type="pmid">10747867</pub-id></mixed-citation></ref></ref-list></back></article>